Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:07:37.592Z.
Calculation as of: 2026-10-06T15:07:37.592Z.
Quote observation: 2026-10-06T15:05:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2ce25f957fe83095360266a8eba44a0c9f304ca71e6017df3a9cc6b1c586d311
EARNINGS YIELD
N/A
MapLight Therapeutics, Inc.
Market Cap
$391.69M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$386.66M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$382.79M
Earnings Yield
N/A
TTM Avg
1.96%
3Y Avg
1.22%
5Y Avg
1.02%
Market Cap
$382.01M
Earnings Yield
N/A
TTM Avg
11.40%
3Y Avg
11.40%
5Y Avg
11.40%
Market Cap
$405.66M
Earnings Yield
N/A
TTM Avg
1.28%
3Y Avg
2.85%
5Y Avg
3.31%
Market Cap
$375.13M
Earnings Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $391.69M | N/A | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $386.66M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $403.15M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $382.79M | N/A | 1.96% | 1.22% | 1.02% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $382.01M | N/A | 11.40% | 11.40% | 11.40% |
| Myriad Genetics, Inc. (MYGN)vs › | $405.66M | N/A | 1.28% | 2.85% | 3.31% |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $375.13M | N/A | 0.02% | 0.02% | 0.02% |
| Neurogene Inc. (NGNE)vs › | $409.91M | N/A | 5.34% | 5.37% | 5.37% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.68M | N/A | 8.82% | 5.78% | 5.78% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
